JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Recruiting · NCT06108050 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2025-12-16 | NCT06108050 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jazz Pharmaceuticals | 60 |
| Merck Sharp & Dohme LLC | 650 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| California Cancer Associates for Research and Excellence | Encinitas | United States | 2 |
| California Cancer Associates for Research and Excellence | Fresno | United States | 1 |
| Duke University Medical Center - Duke Cancer Institute | Durham | United States | 1 |
| Florida Cancer Specialists | Orlando | United States | 8 |
| Sarah Cannon Research Institute at HealthOne | Denver | United States | 34 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital | Philadelphia | United States | 1 |
| Texas Oncology - Baylor Charles A Sammons Cancer Center | Dallas | United States | 1 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Virginia Cancer Specialists | Fairfax | United States | 109 |